ppar-gamma major driver accumulation phenotype adipose tissue t-reg cells 
obesity type diabetes increased markedly past decades parallel one major links two disorders chronic low-grade inflammation prolonged nutrient excess promotes accumulation activation leukocytes visceral adipose tissue vat ultimately tissues leading metabolic abnormalities insulin resistance type diabetes fatty-liver disease although invasion vat pro-inflammatory macrophages considered key event driving adipose-tissue inflammation insulin resistance little known roles immune system cell types processes unique population vat-resident regulatory t t-reg cells recently implicated control inflammatory state adipose tissue thereby insulin sensitivity identify peroxisome proliferator-activated receptor ppar-gamma master regulator adipocyte differentiation crucial molecular orchestrator vat t-reg cell accumulation phenotype function unexpectedly ppar-gamma expression vat t-reg cells necessary complete restoration insulin sensitivity obese mice thiazolidinedione drug pioglitazone findings suggest previously unknown cellular mechanism important class thiazolidinedione drugs provide proof-of-principle discrete populations t-reg cells unique functions can precisely targeted therapeutic ends 
